Literature DB >> 16004694

Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.

C Guilbault1, P Martin, D Houle, M-L Boghdady, M-C Guiot, D Marion, D Radzioch.   

Abstract

To better understand the mechanism of lung infection with Pseudomonas aeruginosa (P. aeruginosa), many techniques have been developed in order to establish lung infection in rodents. A model of chronic lung infection, using tracheotomy to inoculate the bacteria, has been extensively used in the cystic fibrosis (CF) mouse model of lung infection. The cystic fibrosis transmembrane channel (Cftr) knockout (KO) mice are smaller than normal mice and are more sensitive to housing and nutritional conditions, leading to small amounts of animals being available for experiments. Because of these characteristics, and because of the invasiveness of the infection procedure which we, and others, have been using to mimic the lung infection, we sought to find an alternative way to study the inflammatory response during lung P. aeruginosa infection. The technique we describe here consists of the injection of bacterial beads directly into the lungs through the mouth without the need of any tracheal incisions. This technique of direct pulmonary delivery enables much faster infection of the animals compared with the intratracheal technique previously used. The use of this less invasive technique allows the exclusion of the surgery-related inflammation. Our results show that, using the direct pulmonary delivery technique, the KO mice were more susceptible to P. aeruginosa lung infection compared with their wild-type (WT) controls, as shown by their increased weight loss, higher bacterial burden and more elevated polymorphonuclear (PMN) alveolar cell recruitment into the lungs. These differences are consistent with the pathological profiles observed in CF patients infected with P. aeruginosa. Overall, this method simplifies the infection procedure in terms of its duration and invasiveness, and improves the survival rate of the KO mice when compared with the previously used intratracheal procedure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004694     DOI: 10.1258/0023677054306944

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  20 in total

1.  Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.

Authors:  Rika Gomi; Anurag Sharma; Wenzhu Wu; Biin Sung; Stefan Worgall
Journal:  Vaccine       Date:  2017-11-07       Impact factor: 3.641

2.  Evolution of the Immune Response to Chronic Airway Colonization with Aspergillus fumigatus Hyphae.

Authors:  Mirjam Urb; Brendan D Snarr; Gabriella Wojewodka; Mélanie Lehoux; Mark J Lee; Benjamin Ralph; Maziar Divangahi; Irah L King; Toby K McGovern; James G Martin; Richard Fraser; Danuta Radzioch; Donald C Sheppard
Journal:  Infect Immun       Date:  2015-06-29       Impact factor: 3.441

3.  Growth inhibition of pathogenic bacteria by sulfonylurea herbicides.

Authors:  Jason F Kreisberg; Nicholas T Ong; Aishwarya Krishna; Thomas L Joseph; Jing Wang; Catherine Ong; Hui Ann Ooi; Julie C Sung; Chern Chiang Siew; Grace C Chang; Fabrice Biot; Jon Cuccui; Brendan W Wren; Joey Chan; Suppiah P Sivalingam; Lian-Hui Zhang; Chandra Verma; Patrick Tan
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

Review 4.  Highlights of a workshop to discuss targeting inflammation in cystic fibrosis.

Authors:  Katharine H Banner; Hugo De Jonge; Stuart Elborn; Ellena Growcott; Erich Gulbins; Mike Konstan; Rick Moss; Chris Poll; Scott H Randell; Adriano G Rossi; Lorraine Thomas; David Waltz
Journal:  J Cyst Fibros       Date:  2008-11-20       Impact factor: 5.482

5.  Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.

Authors:  A Sandri; M M Lleo; C Signoretto; M Boaretti; F Boschi
Journal:  Clin Exp Immunol       Date:  2020-10-12       Impact factor: 4.330

6.  Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.

Authors:  Yufa Wang; Elvis Cela; Stéphane Gagnon; Neil B Sweezey
Journal:  Respir Res       Date:  2010-11-30

7.  Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator.

Authors:  Sam Tirkos; Susan Newbigging; Van Nguyen; Mary Keet; Cameron Ackerley; Geraldine Kent; Richard F Rozmahel
Journal:  Respir Res       Date:  2006-03-29

8.  A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis.

Authors:  David A Revelli; Julie A Boylan; Frank C Gherardini
Journal:  Front Cell Infect Microbiol       Date:  2012-12-20       Impact factor: 5.293

9.  Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses.

Authors:  Shantelle L LaFayette; Daniel Houle; Trevor Beaudoin; Gabriella Wojewodka; Danuta Radzioch; Lucas R Hoffman; Jane L Burns; Ajai A Dandekar; Nicole E Smalley; Josephine R Chandler; James E Zlosnik; David P Speert; Joanie Bernier; Elias Matouk; Emmanuelle Brochiero; Simon Rousseau; Dao Nguyen
Journal:  Sci Adv       Date:  2015-07-31       Impact factor: 14.136

10.  2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function.

Authors:  Mao Wang; Alex G Gauthier; Thomas P Kennedy; Haichao Wang; Uday Kiran Velagapudi; Tanaji T Talele; Mosi Lin; Jiaqi Wu; LeeAnne Daley; Xiaojing Yang; Vivek Patel; Sung Soo Mun; Charles R Ashby; Lin L Mantell
Journal:  Mol Med       Date:  2021-07-16       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.